Khai Li Chai

1.6k total citations
30 papers, 962 citations indexed

About

Khai Li Chai is a scholar working on Infectious Diseases, Genetics and Hematology. According to data from OpenAlex, Khai Li Chai has authored 30 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Genetics and 8 papers in Hematology. Recurrent topics in Khai Li Chai's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (13 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Khai Li Chai is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (13 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Khai Li Chai collaborates with scholars based in Australia, United Kingdom and Germany. Khai Li Chai's co-authors include Zoe McQuilten, Erica M. Wood, Lise J Estcourt, Nicole Skoetz, Cynthia So‐Osman, Ina Monsef, Vanessa Piechotta, Sarah J Valk, Catherine Kimber and Abigail Lamikanra and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Khai Li Chai

27 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khai Li Chai Australia 14 725 246 125 101 83 30 962
Catherine Kimber United Kingdom 12 573 0.8× 194 0.8× 113 0.9× 69 0.7× 65 0.8× 17 818
Sarah J Valk Netherlands 10 671 0.9× 232 0.9× 123 1.0× 80 0.8× 80 1.0× 15 812
Y.O.Y. Soo Hong Kong 6 1.1k 1.5× 426 1.7× 158 1.3× 56 0.6× 87 1.0× 8 1.3k
Lisa M. Barton United States 6 690 1.0× 334 1.4× 63 0.5× 192 1.9× 47 0.6× 8 1.0k
Jia Feng China 7 656 0.9× 325 1.3× 48 0.4× 161 1.6× 45 0.5× 13 859
Eric J. Duval United States 7 690 1.0× 334 1.4× 63 0.5× 196 1.9× 47 0.6× 10 1.1k
Carlos Salama United States 7 656 0.9× 426 1.7× 33 0.3× 94 0.9× 37 0.4× 12 862
Lianfeng Lu China 8 554 0.8× 260 1.1× 49 0.4× 97 1.0× 29 0.3× 21 758
Dorota Zarębska‐Michaluk Poland 19 535 0.7× 250 1.0× 34 0.3× 95 0.9× 41 0.5× 123 1.1k

Countries citing papers authored by Khai Li Chai

Since Specialization
Citations

This map shows the geographic impact of Khai Li Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khai Li Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khai Li Chai more than expected).

Fields of papers citing papers by Khai Li Chai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khai Li Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khai Li Chai. The network helps show where Khai Li Chai may publish in the future.

Co-authorship network of co-authors of Khai Li Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Khai Li Chai. A scholar is included among the top collaborators of Khai Li Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khai Li Chai. Khai Li Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chai, Khai Li, et al.. (2024). A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies. International Journal of Technology Assessment in Health Care. 40(1). e32–e32. 1 indexed citations
3.
Stadler, Eva, Timothy E. Schlub, Shanchita R. Khan, et al.. (2023). Monoclonal antibody levels and protection from COVID-19. Nature Communications. 14(1). 4545–4545. 26 indexed citations
4.
Kimber, Catherine, Sarah J Valk, Khai Li Chai, et al.. (2023). Hyperimmune immunoglobulin for people with COVID-19. Cochrane Database of Systematic Reviews. 2023(1). CD015167–CD015167. 11 indexed citations
5.
Chai, Khai Li, et al.. (2023). OP95 A Systematic Review Of The Cost And Cost Effectiveness Of Immunoglobulin Treatment In Patients With Hematological Malignancies. International Journal of Technology Assessment in Health Care. 39(S1). S26–S27.
6.
Stadler, Eva, Khai Li Chai, Timothy E. Schlub, et al.. (2023). Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis. The Lancet Microbe. 4(11). e883–e892. 16 indexed citations
7.
Iannizzi, Claire, Khai Li Chai, Vanessa Piechotta, et al.. (2023). Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database of Systematic Reviews. 2023(2). CD013600–CD013600. 22 indexed citations
8.
Iannizzi, Claire, Khai Li Chai, Vanessa Piechotta, et al.. (2023). Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database of Systematic Reviews. 2024(2). CD013600–CD013600. 20 indexed citations
9.
Chai, Khai Li, Robert Weinkove, Philip Crispin, et al.. (2022). Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis. Blood Advances. 7(1). 20–31. 14 indexed citations
10.
Piechotta, Vanessa, Khai Li Chai, Lise J Estcourt, et al.. (2022). SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database of Systematic Reviews. 2022(6). CD014945–CD014945. 27 indexed citations
11.
Valk, Sarah J, Vanessa Piechotta, Khai Li Chai, et al.. (2021). SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database of Systematic Reviews. 13 indexed citations
12.
Piechotta, Vanessa, Claire Iannizzi, Khai Li Chai, et al.. (2021). Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database of Systematic Reviews. 2021(5). 106 indexed citations
13.
Kreuzberger, Nina, Khai Li Chai, Vanessa Piechotta, et al.. (2021). SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database of Systematic Reviews. 48 indexed citations
14.
Valk, Sarah J, Vanessa Piechotta, Catherine Kimber, et al.. (2021). Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2. Cochrane Database of Systematic Reviews. 4 indexed citations
15.
Chai, Khai Li & Merrole Cole‐Sinclair. (2019). Review of available evidence supporting different transfusion thresholds in different patient groups with anemia. Annals of the New York Academy of Sciences. 1450(1). 221–238. 5 indexed citations
16.
Casan, Joshua, Jake Shortt, Eliza A. Hawkes, et al.. (2019). Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma. Scientific Reports. 9(1). 13544–13544. 5 indexed citations
17.
Chua, Chong Chyn, Hui Yin Lim, Khai Li Chai, et al.. (2018). Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma. Bone Marrow Transplantation. 53(9). 1116–1123. 11 indexed citations
18.
Chai, Khai Li, et al.. (2018). BRAF-mutated hairy cell leukaemia with transdifferentiation to histiocytic sarcoma – A case report. Pathology. 50. S102–S102. 1 indexed citations
19.
Chai, Khai Li, et al.. (2017). A Case Report of Hairy Cell Leukemia: An Unusual Presentation. 2(1). 2 indexed citations
20.
Gilbertson, Michael, Zoe McQuilten, George Grigoriadis, et al.. (2016). Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy. Blood. 128(22). 2965–2965. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Kimber Breakdown of academic impact, for papers by Sarah J Valk Breakdown of academic impact, for papers by Y.O.Y. Soo Breakdown of academic impact, for papers by Lisa M. Barton Breakdown of academic impact, for papers by Jia Feng Breakdown of academic impact, for papers by Eric J. Duval Breakdown of academic impact, for papers by Carlos Salama Breakdown of academic impact, for papers by Lianfeng Lu Breakdown of academic impact, for papers by Dorota Zarębska‐Michaluk
Rankless by CCL
2026